Prospective Trials, In Progress
12-02: Multicenter Phase II Study of border zone SR with Bevacizumab chemotherapy in patients with recurrent or progressive glioblastoma multiforme (PI: Dr. Niranjan). Recruitment continues at the University of Pittsburgh.